Uniogen
Tomi Numminen is an experienced executive with a diverse leadership background in the biotechnology and business sectors. Currently serving as the Executive Chairman and CEO at Bioretec Ltd. since May 2016, Tomi also holds the position of Chairman of the Board of Directors at Uniogen. As a founder and Chairman of the Board of Directors at Endicum Ltd. since January 2010, Tomi has demonstrated long-term commitment to organizational leadership. Additional roles include past Chairmanships at Injeq and Labrox, and directorships at BBS-Bioactive Bone Substitutes Oy, Aucor Oy, and Ocuspecto Oy. Tomi previously served as CEO and COO of ReBio Technologies Limited and has experience as a Business Unit Director at Purac Biomaterials. Tomi holds a Master of Science degree in Economics from the University of Turku, obtained between 1992 and 1997.
This person is not in any teams
This person is not in any offices
Uniogen
Three established Finnish life science & diagnostics pioneers Abacus Diagnostica, Labrox and Kaivogen have merged into Uniogen. Uniogen is specialized in molecular and immunoassay diagnostics of infectious diseases, cancer diagnostics, and laboratory instrumentation. We are targeting the global market with new, innovative solutions under development for early cancer detection and for point-of-care testing of infectious diseases, among others.